12 Month Price Forecast For DGX
Distance to DGX Price Forecasts
DGX Price Momentum
๐ค Considering Quest Diagnostics (DGX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 11, 2025 6:25 AM UTC
DGX Analyst Ratings & Price Targets
Based on our analysis of 30 Wall Street analysts, DGX has a neutral consensus with a median price target of $179.00 (ranging from $154.36 to $190.00). The overall analyst rating is Buy (7.9/10). Currently trading at $165.19, the median forecast implies a 8.4% upside. This outlook is supported by 9 Buy, 9 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DGX Analyst Consensus
DGX Price Target Range
Latest DGX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DGX.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Feb 4, 2025 | JP Morgan | Lisa Gill | Neutral | Maintains | $180.00 |
Feb 3, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $170.00 |
Feb 3, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $178.00 |
Feb 3, 2025 | Piper Sandler | David Westenberg | Neutral | Reiterates | $180.00 |
Jan 31, 2025 | Barclays | Stephanie Davis | Equal-Weight | Maintains | $175.00 |
Jan 31, 2025 | Truist Securities | David Macdonald | Hold | Maintains | $182.00 |
Jan 6, 2025 | Leerink Partners | Michael Cherny | Outperform | Upgrade | $174.00 |
Dec 17, 2024 | Morgan Stanley | Erin Wright | Overweight | Upgrade | $172.00 |
Dec 13, 2024 | B of A Securities | Derik De Bruin | Buy | Maintains | $182.00 |
Dec 10, 2024 | Jefferies | Tycho Peterson | Buy | Assumes | $185.00 |
Oct 28, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $165.00 |
Oct 24, 2024 | Mizuho | Ann Hynes | Outperform | Maintains | $174.00 |
Oct 23, 2024 | Citigroup | Patrick Donnelly | Buy | Maintains | $185.00 |
Oct 23, 2024 | Baird | Eric Coldwell | Outperform | Upgrade | $182.00 |
Oct 23, 2024 | UBS | Kevin Caliendo | Neutral | Maintains | $166.00 |
Oct 23, 2024 | Barclays | Stephanie Davis | Equal-Weight | Maintains | $168.00 |
Oct 7, 2024 | Truist Securities | David Macdonald | Hold | Maintains | $165.00 |
Aug 28, 2024 | Evercore ISI Group | Elizabeth Anderson | In-Line | Reinstates | $165.00 |
Aug 27, 2024 | Barclays | Stephanie Davis | Equal-Weight | Maintains | $154.00 |
Jul 29, 2024 | Piper Sandler | David Westenberg | Neutral | Maintains | $150.00 |
Stocks Similar to Quest Diagnostics Inc
The following stocks are similar to Quest Diagnostics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Quest Diagnostics Inc (DGX) Financial Data
Quest Diagnostics Inc has a market capitalization of $18.27B with a P/E ratio of 21.5x. The company generates $9.54B in trailing twelve-month revenue with a 8.8% profit margin.
Revenue growth is +8.4% quarter-over-quarter, while maintaining an operating margin of +14.2% and return on equity of +13.2%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Quest Diagnostics Inc (DGX) Company Overview
About Quest Diagnostics Inc
Provides diagnostic testing and services globally.
The company generates revenue by offering a wide range of diagnostic testing services, including routine and advanced clinical testing, to various stakeholders such as healthcare providers, insurers, and patients. By utilizing a network of laboratories and service centers, it ensures accessibility and efficiency in delivering its services.
Founded in 1967 and headquartered in Secaucus, New Jersey, Quest Diagnostics operates under multiple brands and also offers information technology solutions for healthcare organizations. Its diversified service offerings position it well within the healthcare industry, catering to a broad spectrum of clients including hospitals, employers, and pharmaceutical companies.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
50,000
CEO
Mr. James E. Davis
Country
United States
IPO Year
1996
Website
www.questdiagnostics.comQuest Diagnostics Inc (DGX) Latest News & Analysis
DGX reports strong growth in Q4 2024, driven by high demand for blood tests assessing Alzheimer's disease risk, indicating a positive trend in brain health products.
Strong demand for Alzheimer's blood tests indicates growing market potential for DGX, potentially boosting revenue and attracting investor interest in the healthcare sector.
Zacks Style Scores can guide investors in selecting strong, market-beating stocks for their portfolios.
The Zacks Style Scores can help identify high-potential stocks, offering investors a strategy to enhance portfolio performance and capitalize on market opportunities.
Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.
The Zacks Style Scores can guide investors in selecting high-potential stocks, potentially enhancing portfolio performance and improving returns in a competitive market.
Zacks Style Scores can assist investors in selecting strong, market-beating stocks for their portfolios.
The Zacks Style Scores can guide investors in selecting stocks with potential for higher returns, enhancing portfolio performance amidst market volatility.
Quest Diagnostics EPS Tops Predictions
11 days agoQuest Diagnostics reported Q4 results with adjusted EPS of $2.23, exceeding analyst expectations of $2.18.
Quest Diagnostics' strong Q4 results and EPS exceeding expectations indicate financial health and growth potential, likely boosting investor confidence and stock performance.
Quest Diagnostics (DGX) shares rose over 5% on Thursday, approaching an all-time high, outperforming the S&P 500, which gained 0.8% that day.
Quest Diagnostics' stock nearing an all-time high signals strong investor confidence and outperformance against the broader market, indicating potential growth and stability in the healthcare sector.
Frequently Asked Questions About DGX Stock
What is Quest Diagnostics Inc's (DGX) stock forecast for 2025?
Based on our analysis of 30 Wall Street analysts, Quest Diagnostics Inc (DGX) has a median price target of $179.00. The highest price target is $190.00 and the lowest is $154.36.
Is DGX stock a good investment in 2025?
According to current analyst ratings, DGX has 9 Buy ratings, 9 Hold ratings, and 0 Sell ratings. The stock is currently trading at $165.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for DGX stock?
Wall Street analysts predict DGX stock could reach $179.00 in the next 12 months. This represents a 8.4% increase from the current price of $165.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Quest Diagnostics Inc's business model?
The company generates revenue by offering a wide range of diagnostic testing services, including routine and advanced clinical testing, to various stakeholders such as healthcare providers, insurers, and patients. By utilizing a network of laboratories and service centers, it ensures accessibility and efficiency in delivering its services.
What is the highest forecasted price for DGX Quest Diagnostics Inc?
The highest price target for DGX is $190.00 from at , which represents a 15.0% increase from the current price of $165.19.
What is the lowest forecasted price for DGX Quest Diagnostics Inc?
The lowest price target for DGX is $154.36 from at , which represents a -6.6% decrease from the current price of $165.19.
What is the overall DGX consensus from analysts for Quest Diagnostics Inc?
The overall analyst consensus for DGX is neutral. Out of 30 Wall Street analysts, 9 rate it as Buy, 9 as Hold, and 0 as Sell, with a median price target of $179.00.
How accurate are DGX stock price projections?
Stock price projections, including those for Quest Diagnostics Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.